Letrozole is prescribed for:
- Hormone receptor-positive breast cancer in postmenopausal women
- Adjuvant treatment
- Extended adjuvant treatment
- Metastatic breast cancer
- Oncology hormonal therapy
Back to Medication Guide
Letrozole-Oncology
Generic Name: Letrozole
Brand Names: Femara
Letrozole is an aromatase inhibitor for hormone receptor-positive breast cancer in postmenopausal women.
OncologyAromatase Inhibitor
What It's Used For
Side Effects
Common side effects:
- Hot flashes
- Arthralgia/myalgia
- Fatigue
- Nausea
- Hair thinning
Serious side effects:
- Bone loss/osteoporosis
- Cardiovascular events
- Elevated cholesterol
Additional Information
What is Letrozole?
Letrozole is an aromatase inhibitor that blocks estrogen production in postmenopausal women.
More Effective Than Tamoxifen
In postmenopausal women, aromatase inhibitors are generally more effective than tamoxifen for reducing breast cancer recurrence.
Bone Health
Requires monitoring and treatment for bone loss with calcium, vitamin D, and possibly bisphosphonates.
Learn more at MedlinePlus.
Related Health Conditions
This medication is commonly used to treat or manage the following conditions:
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.
Loading questions...
Ask Dr. Zimmer
Have questions about Letrozole-Oncology? Get expert answers from Dr. Zimmer.
Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.
Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.